640 vs TEL1: Side-by-Side Comparison
Compare China Resources Pharmaceutical Group Limited (640) and SIHUAN PHARMACE (TEL1) side by side: market cap EUR 2.97B vs EUR 820.98M. Financials, growth and model signals on Bullrun.
| Metric | 640 | TEL1 |
|---|---|---|
| Company | China Resources Pharmaceutical Group Limited | SIHUAN PHARMACE |
| Country / Exchange | Hong Kong · F | Hong Kong · F |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | EUR 2.97B | EUR 820.98M |
| P/E ratio | 5.9 | — |
| Dividend yield | 5.14% | 2.68% |
| Valuation model | — | — |
| Revenue (FY2025) | EUR 269.57B | EUR 2.62B |
| Revenue growth YoY | +4.6% | +37.7% |
| Net income | EUR 4.05B | EUR 179.70M |
| Gross margin | 16.5% | 68.8% |
| Diluted EPS | 0.64 | 0.02 |